» Articles » PMID: 38631917

Abortive Infection of Animal Cells: What Goes Wrong

Overview
Journal Annu Rev Virol
Publisher Annual Reviews
Specialty Microbiology
Date 2024 Apr 17
PMID 38631917
Authors
Affiliations
Soon will be listed here.
Abstract

Even if a virus successfully binds to a cell, defects in any of the downstream steps of the viral life cycle can preclude the production of infectious virus particles. Such abortive infections are likely common in nature and can provide fundamental insights into the cell and host tropism of viral pathogens. Research over the past 60 years has revealed an incredible diversity of abortive infections by DNA and RNA viruses in various animal cell types. Here we discuss the general causes of abortive infections and provide specific examples from the literature to illustrate the range of abortive infections that have been reported. We also discuss how abortive infections can have critical roles in shaping host immune responses and in the development of virus-induced cancers. Finally, we describe how abortive infections can be applied to basic and clinical research, underscoring the importance of understanding these fascinating aspects of virus biology.

Citing Articles

An exploration of the natural and acquired immunological mechanisms to high-risk human papillomavirus infection and unmasking immune escape in cervical cancer: A concise synopsis.

Mohammed M, Al-Khafaji Z, Al-Hilli N Tzu Chi Med J. 2025; 37(1):28-41.

PMID: 39850385 PMC: 11753526. DOI: 10.4103/tcmj.tcmj_134_24.


Exploring the genomic basis of Mpox virus-host transmission and pathogenesis.

Young B, Seifert S, Lawson C, Koehler H mSphere. 2024; 9(12):e0057624.

PMID: 39540739 PMC: 11656787. DOI: 10.1128/msphere.00576-24.


Exploiting bacterial effector proteins to uncover evolutionarily conserved antiviral host machinery.

Embry A, Baggett N, Heisler D, White A, de Jong M, Kocsis B PLoS Pathog. 2024; 20(5):e1012010.

PMID: 38753575 PMC: 11098378. DOI: 10.1371/journal.ppat.1012010.


Exploiting Bacterial Effector Proteins to Uncover Evolutionarily Conserved Antiviral Host Machinery.

Embry A, Baggett N, Heisler D, White A, de Jong M, Kocsis B bioRxiv. 2024; .

PMID: 38352400 PMC: 10862796. DOI: 10.1101/2024.01.29.577891.

References
1.
Long J, Idoko-Akoh A, Mistry B, Goldhill D, Staller E, Schreyer J . Species specific differences in use of ANP32 proteins by influenza A virus. Elife. 2019; 8. PMC: 6548507. DOI: 10.7554/eLife.45066. View

2.
Makris S, Bajorek M, Culley F, Goritzka M, Johansson C . Alveolar Macrophages Can Control Respiratory Syncytial Virus Infection in the Absence of Type I Interferons. J Innate Immun. 2016; 8(5):452-63. PMC: 5322584. DOI: 10.1159/000446824. View

3.
Christodoulidou M, Mabbott N . Efficacy of smallpox vaccines against Mpox infections in humans. Immunother Adv. 2023; 3(1):ltad020. PMC: 10598838. DOI: 10.1093/immadv/ltad020. View

4.
Wiebe M, Jamin A . The Barrier to Autointegration Factor: Interlocking Antiviral Defense with Genome Maintenance. J Virol. 2016; 90(8):3806-3809. PMC: 4810535. DOI: 10.1128/JVI.00178-16. View

5.
Whitaker-Dowling P, Youngner J . Vaccinia rescue of VSV from interferon-induced resistance: reversal of translation block and inhibition of protein kinase activity. Virology. 1983; 131(1):128-36. DOI: 10.1016/0042-6822(83)90539-1. View